Arab Finance: Minapharm Pharmaceuticals’ (MIPH) ordinary general meeting (OGM) has accredited disbursing cash dividends of EGP 2.8 per share to shareholders for 2022, the company stated on April 27th.
It is worthy to note that the firm reported a 31.36% year-on-year (YoY) increase in consolidated net profits after tax and minority interest for the full year ended December 31st 2022.
Minapharm Pharmaceuticals is an Egypt-based company engaged in the production and distribution of pharmaceutical products. It is in cooperation with several international pharmaceutical companies and it distributes its products within and outside Egypt.